WHO ICTRP trial
A pilot study to explore the safety of pyridostigmine in constipated palliative…
ACTRN12614000540617 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12614000540617 |
|---|---|
| Public title | A pilot study to explore the safety of pyridostigmine in constipated palliative care patients |
| Scientific title | A pilot study of to assess the safety of pyridostigmine in palliative care patients already prescribed laxatives receiving medications that deliver an anticholinergic load and proven retention of more than 5 radiopaque markers |
| Primary sponsor | Calvary Mater Newcastle |
| Secondary sponsors | Palliative Care Clinical Studies Collaborative (PaCCSC) |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Constipation;Palliative Care; Constipation Palliative Care;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon |
| Interventions | Oral pyridostigmine 60mg twice daily for seven days. The medicines for this study will be stored in the pharmacy prior to dispensing. The used bottles of medication will be collected at the completion of each participant to assess… |
| Registration date | May 21, 2014 |
| Target size | 10 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: